Joy Hsu et al. find that PD-1 is highly expressed on activated NK cells, and its binding to PD-L1 on cancer cells inhibits NK cell degranulation and cytotoxic functions, thereby reducing its antitumor immune responses, promoting tumor immune evasion and progression. The gene discussed is PDCD1; the disease is neoplasm.